Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:54 PM
Ignite Modification Date:
2025-12-24 @ 4:54 PM
NCT ID:
NCT00757250
Eligibility Criteria:
Inclusion Criteria:
* HIV-infected males or non-pregnant, non-breast-feeding females who are \>= 18 years of age;
* CD4+ T-lymphocyte count less than 250 per mm3;
* Successful response to HAART (defined as an HIV RNA viral load of \<50 copies per mL) for a minimum of one year preceding study enrollment.
Exclusion Criteria:
* Opportunistic infection within the 6 months prior to study enrollment
* Active tuberculosis or other mycobacterial infection
* Uncontrolled high blood pressure or congestive heart failure class III or IV
* Systemic glucocorticoid or immunomodulator therapy within 30 days of study entry
* Prior history of Kaposi's sarcoma
* Prior history of lymphoma
* Active substance abuse within the last 30 days
* Uncontrolled psychiatric disorders, including depression
* Abnormal or inadequate liver or renal function
* Inadequate bone marrow function
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00757250
Study Brief:
Protocol Section:
NCT00757250